Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion
- 1 May 1991
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 78 (1) , 60-65
- https://doi.org/10.1111/j.1365-2141.1991.tb04383.x
Abstract
Summary The surface phenotype of neoplastic plasma cells from peripheral blood of plasma cell leukaemia patients and bone marrow of patients with myelomatosis was investigated with two monoclonal antibody panels including 50 selected from the B cell panel of the IVth International Workshop on Leucocyte Differentiation Antigens. The majority of myelomas expressed CD24 (HB8 epitope only), CD38, CD44, CD54, and the antigen recognized by the monoclonal antibody 8A. A range of other antigens may also be expressed including CD10, CD32 (FcR II), CD19, CD20 and MHC Class II. Antigens expressed by myeloma plasma cells can be considered in three groups: (a) antigens associated with lymphocyte and plasma cell differentiation: (b) antigens which are not lineage specific: and (c) molecules concerned with lymphocyte recirculation and intercellular adhesion (CD44 and CD54). The significance of CD44 and CD54 expression by plasma cells and the potential interaction of plasma cells with T lymphocytes and monocytes is discussed.Keywords
This publication has 25 references indexed in Scilit:
- Characterization of a new IgGλ myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myelomaBritish Journal of Haematology, 1990
- A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11 and 14British Journal of Haematology, 1990
- CD44 — A molecule involved in leukocyte adherence and T-cell activationImmunology Today, 1989
- Two human myeloma cell lines, amylase‐producing KMS‐12‐PE and amylase‐non‐producing KMS‐12‐BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32)British Journal of Haematology, 1989
- Peanut agglutinin shows specificity for bone marrow plasma cellsBritish Journal of Haematology, 1989
- Establishment and characterization of a permanent human IgA2/kappa myeloma cell lineBritish Journal of Haematology, 1988
- Establishment and characterization of a human IgA-κ-secreting plasma cell line (MT3)International Journal of Cancer, 1987
- Establishment of a new human myeloma cell line (u-2030) and selection of a hat-sensitive sublineInternational Journal of Cancer, 1987
- A monoclonal antibody reactive with a subset of human plasma cellsBritish Journal of Haematology, 1986
- Two distinct human myeloma cell lines originating from one patient with myelomaInternational Journal of Cancer, 1985